Related Experiment Video

Updated: Feb 14, 2026

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

8.3K

Plasma metabolic profile reveals PGF2α protecting against non-proliferative diabetic retinopathy in patients with

Liyuan Peng1, Bei Sun2, Mingming Liu1

  • 1Tianjin Key Laboratory of Metabolic Diseases and Department of Physiology, Tianjin Medical University, Tianjin 300070, China.

Biochemical and Biophysical Research Communications
|February 7, 2018
PubMed

Insights

Prostaglandin 2α (PGF2α) is decreased in diabetic retinopathy (DR) patients and may protect against its progression. PGF2α enhances retinal pericyte mobility via the FP receptor/RhoA pathway, suggesting a potential therapeutic target for DR.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Biochemistry

Background:

  • Diabetic retinopathy (DR) is a leading cause of blindness, with limited interventions for its early stage, non-proliferative diabetic retinopathy (NPDR).
  • The role of eicosanoids, crucial for vascular homeostasis, in NPDR remains unclear.
  • Investigating eicosanoid profiles can reveal novel insights into NPDR pathogenesis.

Purpose of the Study:

  • To compare plasma eicosanoid profiles in type 2 diabetes patients with and without NPDR.
  • To elucidate the function of specific eicosanoids in retinal pericyte behavior and DR progression.
  • To identify potential therapeutic targets for NPDR.

Main Methods:

  • Plasma eicosanoid profiling using LC-MS/MS in 50 type 2 diabetes patients (NDR vs. NPDR groups).
  • In vitro assays (adhesion, transwell) to assess metabolite effects on bovine retinal pericytes (BRPC).
  • Streptozotocin (STZ)-induced diabetic mouse model for in vivo efficacy testing.

Main Results:

  • Prostaglandin 2α (PGF2α) levels were significantly lower in the NPDR group and negatively correlated with NPDR severity.
  • PGF2α promoted BRPC adhesion and migration by activating the FP receptor and RhoA signaling.
  • PGF2α analogue administration reduced retinal capillary damage in a diabetic mouse model.

Conclusions:

  • PGF2α may act as a protective factor against NPDR progression in type 2 diabetes.
  • PGF2α enhances pericyte mobility through the FP receptor/RhoA pathway, offering a potential therapeutic mechanism.
  • Targeting the PGF2α pathway could be a novel strategy for managing diabetic retinopathy.
Keywords:
Bovine retinal pericyte cellsDiabetic mouse modelDiabetic retinopathyEicosanoid metabolomicsPGF2α

More Related Videos

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy07:45

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Published on: December 30, 2025

449
Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice03:17

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

1.1K

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
511
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K